Brett Matthew Hall - Aug 3, 2021 Form 4 Insider Report for Immuneering Corp (IMRX)

Role
Chief Scientific Officer
Signature
By: /s/ Michael D. Bookman, Attorney-in-Fact for Brett M. Hall
Stock symbol
IMRX
Transactions as of
Aug 3, 2021
Transactions value $
$20,295
Form type
4
Date filed
8/4/2021, 06:05 AM
Previous filing
Jul 29, 2021
Next filing
Dec 22, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMRX Class A Common Stock Conversion of derivative security +5.04K 5.04K Aug 3, 2021 Direct F1
transaction IMRX Class A Common Stock Purchase $20.3K +1.35K +26.85% $15.00 6.39K Aug 3, 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMRX Series A Preferred Stock Conversion of derivative security -1.64K -100% 0 Aug 3, 2021 Class A Common Stock 1.64K Direct F1
transaction IMRX Series B Preferred Stock Conversion of derivative security -3.4K -100% 0 Aug 3, 2021 Class A Common Stock 3.4K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Immediately prior to the closing of the Issuer's initial public offering, each share of preferred stock automatically converted into shares of the Issuer's Class A common stock on a one-for-one basis.